SecSonar.com

Alps Group Inc (ALPS)

Alps Group Inc at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Alps Group Inc (ALPS) is a Biotechnology company based in MY with a market capitalization of $121.8M. Revenue grew 40.3% year-over-year and free cash flow was negative at -$1.7M. This page tracks ALPS's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

MY · 2 employees · IPO Oct 31, 2025

Valuation

Valuation & price

$0.71 · as of May 26, 2026 · -94.1% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$12.01$6.29$0.58Oct 25Feb 26Jul 26Oct 27, 25$12.01Oct 28, 25$11.50Oct 30, 25$3.00Nov 3, 25$1.42Nov 4, 25$0.95Nov 6, 25$0.87Nov 7, 25$0.73Nov 10, 25$0.63Nov 12, 25$0.82Nov 13, 25$0.71Nov 17, 25$0.89Nov 18, 25$0.81Nov 20, 25$0.91Nov 21, 25$1.18Nov 24, 25$1.29Nov 26, 25$1.48Nov 28, 25$1.54Dec 2, 25$1.25Dec 3, 25$1.07Dec 4, 25$1.17Dec 8, 25$1.15Dec 9, 25$1.03Dec 11, 25$1.03Dec 12, 25$0.92Dec 16, 25$0.95Dec 17, 25$0.98Dec 18, 25$1.00Dec 22, 25$0.93Dec 23, 25$0.95Dec 26, 25$0.99Dec 29, 25$0.90Dec 30, 25$0.90Jan 2, 26$0.91Jan 5, 26$1.00Jan 7, 26$0.96Jan 8, 26$0.97Jan 12, 26$0.97Jan 13, 26$1.00Jan 14, 26$0.96Jan 16, 26$0.99Jan 20, 26$1.01Jan 22, 26$1.01Jan 23, 26$0.97Jan 26, 26$1.01Jan 28, 26$0.96Jan 29, 26$0.93Feb 2, 26$0.98Feb 3, 26$0.96Feb 5, 26$0.92Feb 6, 26$0.93Feb 9, 26$0.94Feb 11, 26$0.93Feb 12, 26$0.90Feb 17, 26$0.90Feb 18, 26$0.91Feb 19, 26$0.90Feb 23, 26$0.91Feb 24, 26$0.93Feb 26, 26$0.99Feb 27, 26$0.96Mar 3, 26$0.91Mar 4, 26$0.91Mar 5, 26$0.89Mar 9, 26$0.94Mar 10, 26$1.01Mar 12, 26$1.18Mar 13, 26$1.02Mar 16, 26$1.11Mar 18, 26$1.02Mar 19, 26$1.00Mar 23, 26$1.11Mar 24, 26$1.01Mar 26, 26$1.01Mar 27, 26$1.00Mar 30, 26$0.97Apr 1, 26$1.01Apr 2, 26$1.01Apr 7, 26$0.99Apr 8, 26$1.00Apr 9, 26$1.00Apr 13, 26$0.98Apr 14, 26$1.00Apr 16, 26$1.00Apr 17, 26$1.00Apr 21, 26$0.93Apr 22, 26$0.94Apr 23, 26$0.92Apr 27, 26$0.92Apr 28, 26$0.94Apr 30, 26$0.90May 1, 26$0.91May 4, 26$0.92May 6, 26$0.82May 7, 26$0.83May 11, 26$0.83May 12, 26$0.84May 14, 26$0.86May 15, 26$0.89May 18, 26$0.85May 20, 26$0.69May 21, 26$0.70May 26, 26$0.73May 27, 26$0.74May 28, 26$0.77Jun 1, 26$0.73Jun 2, 26$0.69Jun 4, 26$0.70Jun 5, 26$0.71Jun 9, 26$0.70Jun 10, 26$0.68Jun 11, 26$0.72Jun 15, 26$0.77Jun 16, 26$0.75Jun 18, 26$0.72Jun 22, 26$0.68Jun 23, 26$0.65Jun 25, 26$0.65Jun 26, 26$0.61Jun 30, 26$0.58Jul 2, 26$0.59
$0.5852-week range$12.01
Loading valuation history…

Fundamentals

Key fundamentals

$121.8M

Market cap

40.3%

Revenue growth (YoY)

38.6%

Gross margin

-$1.7M

Free cash flow (USD)

$131.7K

Net debt

2669.8%

Share dilution

0/3

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2021 → 2025

FY 2021$0.00FY 2022$3.6MFY 2024$2.4MFY 2025$3.4M
$0$3.4M

Free cash flow by year

2021 → 2025

FY 2021$-324.9KFY 2023$-388.0KFY 2024$-1.6MFY 2025$-1.7M
-$324.9K-$1.7M

Gross margin by year

2022 → 2025

FY 202255.0%FY 202424.9%FY 202538.6%
55.0%38.6%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: Jun 23, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 6-K filingPatient-Derived Organoid Program LaunchJun 23, 2026Filing
  • 6-K filingAccreditation AnnouncementJun 9, 2026Filing
  • 6-K filingRegulatory UpdateMay 19, 2026Filing
  • 6-K filingManagement ChangeApr 17, 2026Filing

Questions

Frequently asked questions

What is Alps Group Inc's market cap?

Alps Group Inc (ALPS) has a market capitalization of $121.8M.

What is ALPS's P/E ratio?

A meaningful P/E ratio is not available for ALPS — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

When did Alps Group Inc last report earnings?

ALPS last reported earnings on June 23, 2026; the next date is not yet scheduled.

Are insiders buying ALPS stock?

SEC Form 4 filings show no open-market insider buys at Alps Group Inc in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

MIST

Milestone Pharmaceuticals Inc.

$124.1M

CRDF

Cardiff Oncology, Inc.

$124.8M

IKT

Inhibikase Therapeutics, Inc.

$125.3M

GNLX

Genelux Corporation

$114.7M

KRRO

Korro Bio, Inc.

$129.6M

PYXS

Pyxis Oncology, Inc.

$113.7M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.